Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease
Identifieur interne : 000B34 ( Istex/Corpus ); précédent : 000B33; suivant : 000B35Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease
Auteurs : Christine B. Schneider ; Maximilian Pilhatsch ; Martina Rifati ; Wolfgang H. Jost ; Franziska Wodarz ; Georg Ebersbach ; Daniela Djundja ; Gerd Fuchs ; Arne Gies ; Per Odin ; Gerd Reifschneider ; Martin Wolz ; Antonia Bottesi ; Michael Bauer ; Heinz Reichmann ; Alexander StorchSource :
- Movement Disorders [ 0885-3185 ] ; 2010-04-30.
English descriptors
Abstract
Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (P = 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.22985
Links to Exploration step
ISTEX:67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title><author><name sortKey="Schneider, Christine B" sort="Schneider, Christine B" uniqKey="Schneider C" first="Christine B." last="Schneider">Christine B. Schneider</name><affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Pilhatsch, Maximilian" sort="Pilhatsch, Maximilian" uniqKey="Pilhatsch M" first="Maximilian" last="Pilhatsch">Maximilian Pilhatsch</name><affiliation><mods:affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Rifati, Martina" sort="Rifati, Martina" uniqKey="Rifati M" first="Martina" last="Rifati">Martina Rifati</name><affiliation><mods:affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Jost, Wolfgang H" sort="Jost, Wolfgang H" uniqKey="Jost W" first="Wolfgang H." last="Jost">Wolfgang H. Jost</name><affiliation><mods:affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Wodarz, Franziska" sort="Wodarz, Franziska" uniqKey="Wodarz F" first="Franziska" last="Wodarz">Franziska Wodarz</name><affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation></affiliation></author><author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name><affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation></affiliation></author><author><name sortKey="Djundja, Daniela" sort="Djundja, Daniela" uniqKey="Djundja D" first="Daniela" last="Djundja">Daniela Djundja</name><affiliation><mods:affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</mods:affiliation></affiliation></author><author><name sortKey="Fuchs, Gerd" sort="Fuchs, Gerd" uniqKey="Fuchs G" first="Gerd" last="Fuchs">Gerd Fuchs</name><affiliation><mods:affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</mods:affiliation></affiliation></author><author><name sortKey="Gies, Arne" sort="Gies, Arne" uniqKey="Gies A" first="Arne" last="Gies">Arne Gies</name><affiliation><mods:affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</mods:affiliation></affiliation></author><author><name sortKey="Odin, Per" sort="Odin, Per" uniqKey="Odin P" first="Per" last="Odin">Per Odin</name><affiliation><mods:affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</mods:affiliation></affiliation></author><author><name sortKey="Reifschneider, Gerd" sort="Reifschneider, Gerd" uniqKey="Reifschneider G" first="Gerd" last="Reifschneider">Gerd Reifschneider</name><affiliation><mods:affiliation>Neuro Centrum Odenwald, Erbach, Germany</mods:affiliation></affiliation></author><author><name sortKey="Wolz, Martin" sort="Wolz, Martin" uniqKey="Wolz M" first="Martin" last="Wolz">Martin Wolz</name><affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Bottesi, Antonia" sort="Bottesi, Antonia" uniqKey="Bottesi A" first="Antonia" last="Bottesi">Antonia Bottesi</name><affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Bauer, Michael" sort="Bauer, Michael" uniqKey="Bauer M" first="Michael" last="Bauer">Michael Bauer</name><affiliation><mods:affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Reichmann, Heinz" sort="Reichmann, Heinz" uniqKey="Reichmann H" first="Heinz" last="Reichmann">Heinz Reichmann</name><affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Storch, Alexander" sort="Storch, Alexander" uniqKey="Storch A" first="Alexander" last="Storch">Alexander Storch</name><affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1002/mds.22985</idno><idno type="url">https://api.istex.fr/document/67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000B34</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title><author><name sortKey="Schneider, Christine B" sort="Schneider, Christine B" uniqKey="Schneider C" first="Christine B." last="Schneider">Christine B. Schneider</name><affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Pilhatsch, Maximilian" sort="Pilhatsch, Maximilian" uniqKey="Pilhatsch M" first="Maximilian" last="Pilhatsch">Maximilian Pilhatsch</name><affiliation><mods:affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Rifati, Martina" sort="Rifati, Martina" uniqKey="Rifati M" first="Martina" last="Rifati">Martina Rifati</name><affiliation><mods:affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Jost, Wolfgang H" sort="Jost, Wolfgang H" uniqKey="Jost W" first="Wolfgang H." last="Jost">Wolfgang H. Jost</name><affiliation><mods:affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Wodarz, Franziska" sort="Wodarz, Franziska" uniqKey="Wodarz F" first="Franziska" last="Wodarz">Franziska Wodarz</name><affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation></affiliation></author><author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name><affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation></affiliation></author><author><name sortKey="Djundja, Daniela" sort="Djundja, Daniela" uniqKey="Djundja D" first="Daniela" last="Djundja">Daniela Djundja</name><affiliation><mods:affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</mods:affiliation></affiliation></author><author><name sortKey="Fuchs, Gerd" sort="Fuchs, Gerd" uniqKey="Fuchs G" first="Gerd" last="Fuchs">Gerd Fuchs</name><affiliation><mods:affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</mods:affiliation></affiliation></author><author><name sortKey="Gies, Arne" sort="Gies, Arne" uniqKey="Gies A" first="Arne" last="Gies">Arne Gies</name><affiliation><mods:affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</mods:affiliation></affiliation></author><author><name sortKey="Odin, Per" sort="Odin, Per" uniqKey="Odin P" first="Per" last="Odin">Per Odin</name><affiliation><mods:affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</mods:affiliation></affiliation></author><author><name sortKey="Reifschneider, Gerd" sort="Reifschneider, Gerd" uniqKey="Reifschneider G" first="Gerd" last="Reifschneider">Gerd Reifschneider</name><affiliation><mods:affiliation>Neuro Centrum Odenwald, Erbach, Germany</mods:affiliation></affiliation></author><author><name sortKey="Wolz, Martin" sort="Wolz, Martin" uniqKey="Wolz M" first="Martin" last="Wolz">Martin Wolz</name><affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Bottesi, Antonia" sort="Bottesi, Antonia" uniqKey="Bottesi A" first="Antonia" last="Bottesi">Antonia Bottesi</name><affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Bauer, Michael" sort="Bauer, Michael" uniqKey="Bauer M" first="Michael" last="Bauer">Michael Bauer</name><affiliation><mods:affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Reichmann, Heinz" sort="Reichmann, Heinz" uniqKey="Reichmann H" first="Heinz" last="Reichmann">Heinz Reichmann</name><affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author><author><name sortKey="Storch, Alexander" sort="Storch, Alexander" uniqKey="Storch A" first="Alexander" last="Storch">Alexander Storch</name><affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-04-30">2010-04-30</date><biblScope unit="vol">25</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="777">777</biblScope><biblScope unit="page" to="783">783</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2</idno><idno type="DOI">10.1002/mds.22985</idno><idno type="ArticleID">MDS22985</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>BDI‐1A</term><term>Parkinson's disease</term><term>WHO‐Five Well‐being Index</term><term>depression</term><term>screening</term><term>validity</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (P = 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Christine B. Schneider MD</name><affiliations><json:string>Department of Neurology, Dresden University of Technology, Dresden, Germany</json:string></affiliations></json:item><json:item><name>Maximilian Pilhatsch MD</name><affiliations><json:string>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</json:string></affiliations></json:item><json:item><name>Martina Rifati</name><affiliations><json:string>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</json:string></affiliations></json:item><json:item><name>Wolfgang H. Jost MD</name><affiliations><json:string>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</json:string></affiliations></json:item><json:item><name>Franziska Wodarz</name><affiliations><json:string>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</json:string></affiliations></json:item><json:item><name>Georg Ebersbach MD</name><affiliations><json:string>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</json:string></affiliations></json:item><json:item><name>Daniela Djundja</name><affiliations><json:string>Parkinson Clinic Wolfach, Wolfach, Germany</json:string></affiliations></json:item><json:item><name>Gerd Fuchs MD</name><affiliations><json:string>Parkinson Clinic Wolfach, Wolfach, Germany</json:string></affiliations></json:item><json:item><name>Arne Gies</name><affiliations><json:string>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</json:string></affiliations></json:item><json:item><name>Per Odin MD</name><affiliations><json:string>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</json:string></affiliations></json:item><json:item><name>Gerd Reifschneider MD</name><affiliations><json:string>Neuro Centrum Odenwald, Erbach, Germany</json:string></affiliations></json:item><json:item><name>Martin Wolz MD</name><affiliations><json:string>Department of Neurology, Dresden University of Technology, Dresden, Germany</json:string></affiliations></json:item><json:item><name>Antonia Bottesi MD</name><affiliations><json:string>Department of Neurology, Dresden University of Technology, Dresden, Germany</json:string></affiliations></json:item><json:item><name>Michael Bauer MD, PhD</name><affiliations><json:string>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</json:string></affiliations></json:item><json:item><name>Heinz Reichmann PhD</name><affiliations><json:string>Department of Neurology, Dresden University of Technology, Dresden, Germany</json:string></affiliations></json:item><json:item><name>Alexander Storch MD</name><affiliations><json:string>Department of Neurology, Dresden University of Technology, Dresden, Germany</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>depression</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>WHO‐Five Well‐being Index</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>validity</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>screening</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>BDI‐1A</value></json:item></subject><language><json:string>eng</json:string></language><abstract>Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (P = 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society</abstract><qualityIndicators><score>6.956</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1107</abstractCharCount><pdfWordCount>18036</pdfWordCount><pdfCharCount>118703</pdfCharCount><pdfPageCount>29</pdfPageCount><abstractWordCount>163</abstractWordCount></qualityIndicators><title>Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title><genre><json:string>Serial article</json:string></genre><host><volume>25</volume><pages><total>7</total><last>783</last><first>777</first></pages><issn><json:string>0885-3185</json:string></issn><issue>6</issue><subject><json:item><value>Brief Report</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2010</publicationDate><copyrightDate>2010</copyrightDate><doi><json:string>10.1002/mds.22985</json:string></doi><id>67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2010</date></publicationStmt><notesStmt><note type="content">*Potential conflict of interest: Nothing to report.</note><note>Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title><author><persName><forename type="first">Christine B.</forename><surname>Schneider</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation></author><author><persName><forename type="first">Maximilian</forename><surname>Pilhatsch</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</affiliation></author><author><persName><forename type="first">Martina</forename><surname>Rifati</surname></persName><affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</affiliation></author><author><persName><forename type="first">Wolfgang H.</forename><surname>Jost</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</affiliation></author><author><persName><forename type="first">Franziska</forename><surname>Wodarz</surname></persName><affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation></author><author><persName><forename type="first">Georg</forename><surname>Ebersbach</surname><roleName type="degree">MD</roleName></persName><affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation></author><author><persName><forename type="first">Daniela</forename><surname>Djundja</surname></persName><affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</affiliation></author><author><persName><forename type="first">Gerd</forename><surname>Fuchs</surname><roleName type="degree">MD</roleName></persName><affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</affiliation></author><author><persName><forename type="first">Arne</forename><surname>Gies</surname></persName><affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</affiliation></author><author><persName><forename type="first">Per</forename><surname>Odin</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</affiliation></author><author><persName><forename type="first">Gerd</forename><surname>Reifschneider</surname><roleName type="degree">MD</roleName></persName><affiliation>Neuro Centrum Odenwald, Erbach, Germany</affiliation></author><author><persName><forename type="first">Martin</forename><surname>Wolz</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation></author><author><persName><forename type="first">Antonia</forename><surname>Bottesi</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation></author><author><persName><forename type="first">Michael</forename><surname>Bauer</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</affiliation></author><author><persName><forename type="first">Heinz</forename><surname>Reichmann</surname><roleName type="degree">PhD</roleName></persName><affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation></author><author><persName><forename type="first">Alexander</forename><surname>Storch</surname><roleName type="degree">MD</roleName></persName><note type="correspondence"><p>Correspondence: Department of Neurology, Dresden University of Technology, Fetscherstrasse 74, Dresden 01307, Germany</p></note><affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-04-30"></date><biblScope unit="vol">25</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="777">777</biblScope><biblScope unit="page" to="783">783</biblScope></imprint></monogr><idno type="istex">67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2</idno><idno type="DOI">10.1002/mds.22985</idno><idno type="ArticleID">MDS22985</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2010</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (P = 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson's disease</term></item><item><term>depression</term></item><item><term>WHO‐Five Well‐being Index</term></item><item><term>validity</term></item><item><term>screening</term></item><item><term>BDI‐1A</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2009-06-15">Received</change><change when="2009-12-04">Registration</change><change when="2010-04-30">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="60"><doi origin="wiley" registered="yes">10.1002/mds.v25:6</doi><numberingGroup><numbering type="journalVolume" number="25">25</numbering><numbering type="journalIssue">6</numbering></numberingGroup><coverDate startDate="2010-04-30">30 April 2010</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="190" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.22985</doi><idGroup><id type="unit" value="MDS22985"></id></idGroup><countGroup><count type="pageTotal" number="7"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 2010 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2009-06-15"></event><event type="manuscriptRevised" date="2009-12-01"></event><event type="manuscriptAccepted" date="2009-12-04"></event><event type="firstOnline" date="2010-01-27"></event><event type="publishedOnlineFinalForm" date="2010-04-26"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2010-01-27"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.5.2 mode:FullText" date="2011-08-12"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">777</numbering><numbering type="pageLast">783</numbering></numberingGroup><correspondenceTo>Department of Neurology, Dresden University of Technology, Fetscherstrasse 74, Dresden 01307, Germany</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS22985.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="2"></count><count type="referenceTotal" number="29"></count><count type="wordTotal" number="4924"></count></countGroup><titleGroup><title type="main" xml:lang="en">Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease<link href="#fn1"></link></title><title type="short" xml:lang="en">Validation of WHO‐Five in Parkinson's Disease</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Christine B.</givenNames><familyName>Schneider</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Maximilian</givenNames><familyName>Pilhatsch</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Martina</givenNames><familyName>Rifati</familyName></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Wolfgang H.</givenNames><familyName>Jost</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af4"><personName><givenNames>Franziska</givenNames><familyName>Wodarz</familyName></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af4"><personName><givenNames>Georg</givenNames><familyName>Ebersbach</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au7" creatorRole="author" affiliationRef="#af5"><personName><givenNames>Daniela</givenNames><familyName>Djundja</familyName></personName></creator><creator xml:id="au8" creatorRole="author" affiliationRef="#af5"><personName><givenNames>Gerd</givenNames><familyName>Fuchs</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au9" creatorRole="author" affiliationRef="#af6"><personName><givenNames>Arne</givenNames><familyName>Gies</familyName></personName></creator><creator xml:id="au10" creatorRole="author" affiliationRef="#af6"><personName><givenNames>Per</givenNames><familyName>Odin</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au11" creatorRole="author" affiliationRef="#af7"><personName><givenNames>Gerd</givenNames><familyName>Reifschneider</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au12" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Martin</givenNames><familyName>Wolz</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au13" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Antonia</givenNames><familyName>Bottesi</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au14" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Michael</givenNames><familyName>Bauer</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au15" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Heinz</givenNames><familyName>Reichmann</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au16" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Alexander</givenNames><familyName>Storch</familyName><degrees>MD</degrees></personName><contactDetails><email normalForm="alexander.storch@neuro.med.tu-dresden.de">alexander.storch@neuro.med.tu‐dresden.de</email></contactDetails></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="DE" type="organization"><unparsedAffiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="DE" type="organization"><unparsedAffiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="DE" type="organization"><unparsedAffiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</unparsedAffiliation></affiliation><affiliation xml:id="af4" countryCode="DE" type="organization"><unparsedAffiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</unparsedAffiliation></affiliation><affiliation xml:id="af5" countryCode="DE" type="organization"><unparsedAffiliation>Parkinson Clinic Wolfach, Wolfach, Germany</unparsedAffiliation></affiliation><affiliation xml:id="af6" countryCode="DE" type="organization"><unparsedAffiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</unparsedAffiliation></affiliation><affiliation xml:id="af7" countryCode="DE" type="organization"><unparsedAffiliation>Neuro Centrum Odenwald, Erbach, Germany</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson's disease</keyword><keyword xml:id="kwd2">depression</keyword><keyword xml:id="kwd3">WHO‐Five Well‐being Index</keyword><keyword xml:id="kwd4">validity</keyword><keyword xml:id="kwd5">screening</keyword><keyword xml:id="kwd6">BDI‐1A</keyword></keywordGroup><fundingInfo><fundingAgency>Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany</fundingAgency></fundingInfo><supportingInformation><p> Additional Supporting Information may be found in the online version of this article. </p></supportingInformation><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (<i>P</i> = 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p>Potential conflict of interest: Nothing to report.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Validation of WHO‐Five in Parkinson's Disease</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title></titleInfo><name type="personal"><namePart type="given">Christine B.</namePart><namePart type="family">Schneider</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Maximilian</namePart><namePart type="family">Pilhatsch</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Martina</namePart><namePart type="family">Rifati</namePart><affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Wolfgang H.</namePart><namePart type="family">Jost</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Franziska</namePart><namePart type="family">Wodarz</namePart><affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Georg</namePart><namePart type="family">Ebersbach</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Daniela</namePart><namePart type="family">Djundja</namePart><affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Gerd</namePart><namePart type="family">Fuchs</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Arne</namePart><namePart type="family">Gies</namePart><affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Per</namePart><namePart type="family">Odin</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Gerd</namePart><namePart type="family">Reifschneider</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Neuro Centrum Odenwald, Erbach, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Martin</namePart><namePart type="family">Wolz</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Antonia</namePart><namePart type="family">Bottesi</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Michael</namePart><namePart type="family">Bauer</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Heinz</namePart><namePart type="family">Reichmann</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Alexander</namePart><namePart type="family">Storch</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation><description>Correspondence: Department of Neurology, Dresden University of Technology, Fetscherstrasse 74, Dresden 01307, Germany</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2010-04-30</dateIssued><dateCaptured encoding="w3cdtf">2009-06-15</dateCaptured><dateValid encoding="w3cdtf">2009-12-04</dateValid><copyrightDate encoding="w3cdtf">2010</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="tables">2</extent><extent unit="references">29</extent><extent unit="words">4924</extent></physicalDescription><abstract lang="en">Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (P = 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society</abstract><note type="content">*Potential conflict of interest: Nothing to report.</note><note type="funding">Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany</note><subject lang="en"><genre>Keywords</genre><topic>Parkinson's disease</topic><topic>depression</topic><topic>WHO‐Five Well‐being Index</topic><topic>validity</topic><topic>screening</topic><topic>BDI‐1A</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><note type="content"> Additional Supporting Information may be found in the online version of this article.</note><subject><genre>article category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><detail type="issue"><caption>no.</caption><number>6</number></detail><extent unit="pages"><start>777</start><end>783</end><total>7</total></extent></part></relatedItem><identifier type="istex">67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2</identifier><identifier type="DOI">10.1002/mds.22985</identifier><identifier type="ArticleID">MDS22985</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2010 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B34 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000B34 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2
|texte= Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |